Parallel Advisors »

Summit Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $875 50 17.50
2025-09-30 $39k 1.9k 20.66

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Cvb Finl Corp Stock (CVBF)
Janus Henderson Mortgage-backed Securities Etf Etf (JMBS)
Vanguard Large Cap Etf (VV)
Avantis International Equity Etf Etf (AVDE)
Ishares Core Msci Eafe Etf Etf (IEFA)

View all positions for Parallel Advisors

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
Vanguard Group
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Geode Capital Management
Polymer Capital Management
Pictet Asset Management Holding SA
Norges Bank Investment Management
Apeiron Capital
TD Asset Management
Standard Life Aberdeen
Charles Schwab Investment Management

View all funds holding Summit Therapeutics